ResearchDx news

ResearchDx/Targeted Genomics receives FDA 510 (k) Clearance!

June 20, 2025

ResearchDx and Targeted Genomics receive FDA 510(k) clearance for GlutenID

ResearchDx and Targeted Genomics are thrilled to announce that the GlutenID Celiac Genetic Health Risk Test has received FDA 510(k) clearance (K241456) with testing to be performed at ResearchDx’s PacificDx facility.

Press Release

Read the FDA 510(k) decision summary for K241456 (PDF)

@PacificDx

Working on a diagnostic of your own?

From biomarker discovery to FDA clearance and CLIA testing, we can help.